Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 24, 2005
April 22, 2020
9fb2afd0-d696-4043-9e1d-40673dcaf63a
Related Documents
Premarketing Risk Assessment: Guidance for Industry
Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
Guidance for Review Staff and Industry Good Review Management Principles and Practices for PDUFA Products
Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
Development and Use of Risk Minimization Action Plans: Guidance for Industry
Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox